DGAP-News: CerMed International Inc.: CerMed International to Open Vermont R&D Facility
(firmenpresse) - DGAP-News: CerMed International Inc. / Key word(s):
Agreement/Corporate Action
CerMed International Inc.: CerMed International to Open Vermont R&D
Facility
15.06.2011 / 09:30
---------------------------------------------------------------------
FOR IMMEDIATE RELEASE
CONTACT
CerMed International
(831) 920 2275 (o)
info(at)cermedint.com
www.cermedint.com
CerMed International to Open Vermont R&D Facility
Monterey, CA - May 15, 2011 - CerMed International, Inc. based in Monterey,
CA and a global company focused on women's health, announces the
establishment of an R&D facility located in Essex Junction, Vermont. The
laboratory will focus initially on finalizing the development of a
point-of-care screening system for cervical cancer that is designed to
replace the nearly 160 million Pap smears conducted each year worldwide.
'We believe our new platform will significantly improve upon the current
standard of cervical cancer screening, and in the future can be directed
toward additional rapid testing for other infectious or sexually
transmitted diseases', said CerMed's Chief Technology Officer, Dr. Paul
Vichi, who will be directing operations at the facility.
In conjunction with the new lab, CerMed is pleased to announce that it has
hired Research Scientist Dr. Jonathan Rud, Ph.D., who will focus on
protocol development and testing of the redesigned POC platform. Dr. Rud is
a former Post-doctoral Fellow in the Department of Medicine/Immunology at
the University of Vermont, and a graduate from the University of
Massachusetts' department of Molecular and Cellular Biology. His previous
efforts were directed at the mammalian response to influenza virus and
regulation of cell signaling important in apoptosis, a critical process for
controlling tumor development. Dr Rud adds to CerMed's talents in the areas
of immunology and molecular biology; he will play an important role in the
product development process.
About CerMed International
CerMed International, Inc. is an emerging global medical device company
that develops products and systems that help improve the health of women
worldwide. These lower cost products will aid in reducing the risk of
female reproductive diseases. They will enable women's health initiatives
to be brought to the underserved regions of the world and empower women to
personally take steps to reduce the risk of HIV and other STD's.
For information: http://www.cermedint.com
Contact: info(at)cermedint.com
Phone: 831-920-2275
###
End of Corporate News
---------------------------------------------------------------------
15.06.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
128549 15.06.2011
Datum: 15.06.2011 - 09:30 Uhr
Sprache: Deutsch
News-ID 34384
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 217 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: CerMed International Inc.: CerMed International to Open Vermont R&D Facility"
steht unter der journalistisch-redaktionellen Verantwortung von
CerMed International Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
